Literature DB >> 12476301

BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.

Stephanie Salesse1, Catherine M Verfaillie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12476301     DOI： 10.1038/sj.onc.1206082

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  29 in total

Review 1.  Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events.

Authors:  Shenq-Shyang Huang; Nan-Shan Chang
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-08

Review 2.  High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.

Authors:  Genevieve Conant; Benjamin Fook Lun Lai; Rick Xing Ze Lu; Anastasia Korolj; Erika Yan Wang; Milica Radisic
Journal:  Stem Cell Rev Rep       Date:  2017-06       Impact factor: 5.739

3.  Bcr-abl silencing by specific small-interference RNA expression vector as a potential treatment for chronic myeloid leukemia.

Authors:  Ali Zaree Mahmodabady; Hamid Reza Javadi; Mehdi Kamali; Ali Najafi; Zahra Hojati
Journal:  Iran Biomed J       Date:  2010 Jan-Apr

Review 4.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

5.  CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model.

Authors:  Yu-Ting Tan; Lin Ye; Fei Xie; Jiaming Wang; Markus Müschen; Sai-Juan Chen; Yuet Wai Kan; Han Liu
Journal:  Haematologica       Date:  2019-09-19       Impact factor: 9.941

Review 6.  From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview.

Authors:  Carlo Gabriele Tocchetti; Christian Cadeddu; Daniela Di Lisi; Saveria Femminò; Rosalinda Madonna; Donato Mele; Ines Monte; Giuseppina Novo; Claudia Penna; Alessia Pepe; Paolo Spallarossa; Gilda Varricchi; Concetta Zito; Pasquale Pagliaro; Giuseppe Mercuro
Journal:  Antioxid Redox Signal       Date:  2017-05-15       Impact factor: 8.401

7.  Fisetin and hesperetin induced apoptosis and cell cycle arrest in chronic myeloid leukemia cells accompanied by modulation of cellular signaling.

Authors:  Aysun Adan; Yusuf Baran
Journal:  Tumour Biol       Date:  2015-09-25

8.  CRISPR/Cas9 knockouts reveal genetic interaction between strain-transcendent erythrocyte determinants of Plasmodium falciparum invasion.

Authors:  Usheer Kanjee; Christof Grüring; Mudit Chaand; Kai-Min Lin; Elizabeth Egan; Jale Manzo; Patrick L Jones; Tiffany Yu; Robert Barker; Michael P Weekes; Manoj T Duraisingh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-10-19       Impact factor: 11.205

9.  Short loop functional commonality identified in leukaemia proteome highlights crucial protein sub-networks.

Authors:  Sun Sook Chung; Joseph C F Ng; Anna Laddach; N Shaun B Thomas; Franca Fraternali
Journal:  NAR Genom Bioinform       Date:  2021-03-01

10.  c-Abl is an upstream regulator of acid sphingomyelinase in apoptosis induced by inhibition of integrins αvβ3 and αvβ5.

Authors:  Xiuhai Ren; Jingying Xu; Jason P Cooper; Min H Kang; Anat Erdreich-Epstein
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.